Zhejiang Tianyu Pharmaceutical Co Ltd (300702) — Capital Reinvestment Ratio

Latest as of September 2025: 0.30x

Zhejiang Tianyu Pharmaceutical Co Ltd (300702) has a Capital Reinvestment Ratio of 0.30x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥233.18 Million) in capital expenditures (CN¥70.00 Million). See how much free cash does Zhejiang Tianyu Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.30x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥233.18 Million
CNY

Capital Expenditures

CN¥70.00 Million
CNY

Data as of

Sep 2025
Most recent filing

Zhejiang Tianyu Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2024)

This chart tracks Zhejiang Tianyu Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 9 annual periods.

Annual Capital Reinvestment Ratio for Zhejiang Tianyu Pharmaceutical Co Ltd (2013–2024)

Year-by-year Capital Reinvestment Ratio for Zhejiang Tianyu Pharmaceutical Co Ltd from 2013 to 2024. For live market cap and broader valuation context, see Zhejiang Tianyu Pharmaceutical Co Ltd (300702) market capitalisation.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.49x CN¥344.64 Million CN¥168.95 Million ▼ -39.7%
2020 0.81x CN¥622.18 Million CN¥506.05 Million ▼ -1.7%
2019 0.83x CN¥427.84 Million CN¥354.10 Million ▼ -63.8%
2018 2.29x CN¥78.57 Million CN¥179.89 Million ▲ +80.1%
2017 1.27x CN¥88.52 Million CN¥112.54 Million ▲ +95.0%
2016 0.65x CN¥164.74 Million CN¥107.44 Million ▼ -84.6%
2015 4.24x CN¥14.75 Million CN¥62.59 Million ▲ +326.7%
2014 0.99x CN¥80.44 Million CN¥79.99 Million ▼ -42.2%
2013 1.72x CN¥39.73 Million CN¥68.31 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow